keyword
https://read.qxmd.com/read/38618668/influence-of-manipulative-skills-on-quality-of-life-and-activities-of-daily-living-in-multiple-sclerosis
#1
JOURNAL ARTICLE
S Rodríguez-Menéndez, R M Martínez-Piédrola, M Menéndez-González, M Pérez-de-Heredia-Torres
INTRODUCTION: More than 50% of patients diagnosed with multiple sclerosis report problems with manipulative function and impairments in their daily lives due to this disorder. Therefore, the aim of the present study is to determine how pinch strength, prey strength and manipulative dexterity affect the quality of life and personal autonomy of people diagnosed with multiple sclerosis and to study whether there is a difference in these aspects between different types of multiple sclerosis...
April 16, 2024: Revista de Neurologia
https://read.qxmd.com/read/38614530/multiple-and-hereditary-renal-tumors-a-review-for-radiologists
#2
JOURNAL ARTICLE
M Á Corral de la Calle, J Encinas de la Iglesia, G C Fernández Pérez, A Fraino, M Repollés Cobaleda
80% of renal carcinomas (RC) are diagnosed incidentally by imaging. 2-4% of "sporadic" multifocality and 5-8% of hereditary syndromes are accepted, probably with underestimation. Multifocality, young age, familiar history, syndromic data, and certain histologies lead to suspicion of hereditary syndrome. Each tumor must be studied individually, with a multidisciplinary evaluation of the patient. Nephron-sparing therapeutic strategies and a radioprotective diagnostic approach are recommended. Relevant data for the radiologist in major RC hereditary syndromes are presented: von-Hippel-Lindau, Chromosome-3 translocation, BRCA-associated protein-1 mutation, RC associated with succinate dehydrogenase deficiency, PTEN, hereditary papillary RC, Papillary thyroid cancer- Papillary RC, Hereditary leiomyomatosis and RC, Birt-Hogg-Dubé, Tuberous sclerosis complex, Lynch, Xp11...
2024: Radiología
https://read.qxmd.com/read/38593979/bilateral-macular-edema-in-sistemic-sclerosis
#3
M Zamorano Aleixandre, I Redondo Marcos, J J González-López
Systemic sclerosis is a chronic, autoimmune, multisystem disease characterized by vascular dysfunction, chronic inflammation and widespread fibrosis. Although vascular involvement commonly manifests in the skin, it can also affect other organs, including the eyes. The characteristic vascular alteration is an obliterative fibroproliferative vasculopathy leading to hypoxia and tissue ischemia. We present a case of bilateral macular edema in a patient diagnosed with systemic sclerosis, as a consequence of retinal and choroidal vascular changes...
April 7, 2024: Archivos de la Sociedad Española de Oftalmología
https://read.qxmd.com/read/38553104/relationship-between-inflammation-and-oxidative-stress-and-its-effect-on-multiple-sclerosis
#4
REVIEW
E J Ramos-González, O K Bitzer-Quintero, G Ortiz, J J Hernández-Cruz, L J Ramírez-Jirano
INTRODUCTION: This paper highlights the relationship of inflammation and oxidative stress as damage mechanisms of Multiple Sclerosis (MS), considered an inflammatory and autoimmune disease. DEVELOPMENT: The oxidative stress concept has been defined by an imbalance between oxidants and antioxidants in favor of the oxidants. There is necessary to do physiological functions, like the respiration chain, but in certain conditions, the production of reactive species overpassed the antioxidant systems, which could cause tissue damage...
April 2024: Neurología
https://read.qxmd.com/read/38538448/pharmaceutical-recommendations-for-therapeutic-appropriateness-in-multiple-sclerosis-patients
#5
JOURNAL ARTICLE
María Del Mar Sánchez Suárez, Alicia Martín Roldán, Maria Rosa Cantudo Cuenca, Alberto Jiménez Morales
OBJECTIVE: To determine the prevalence of PIMDINAC criteria and to implement pharmacological interventions in a population with multiple sclerosis over 55 years of age. METHODS: Retrospective observational open-label study including patients with multiple sclerosis aged 55 years and older between December 2022 and February 2023. The main variable determined was the percentage of compliance with the PIMDINAC criteria. RESULTS: Ninety-five patients were included, with the presence of PIMDINAC criteria detected in 67...
March 26, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38502167/-core-data-set-for-real-world-data-in-multiple-sclerosis-customization-for-latin-america-from-a-global-task-force-recommendation
#6
JOURNAL ARTICLE
J I Rojas, F Gracia, T Parciak, R Alonso, J Becker, I Treviño-Frenk, M Alonso-Serena, D Giunta, P Abad, E Carnero-Contentti, A Carrá, E P Correa-Díaz, J Correale, E Cristiano, J Flores, M Fruns, L Galleguillos, O Garcea, F Hamuy, M Lana-Peixoto, C Navas, R Pappais-Alvarenga, L Patrucco, V Rivera, S Tenembaum, M C Ysrraelit, L M Peeters
INTRODUCTION: The primary objective of the core data set is to reduce heterogeneity and promote harmonization among data sources in EM, thereby reducing the time needed to execute real life data collection efforts. Recently, a group led by the Multiple Sclerosis Data Alliance has developed a core data set for collecting real-world data on multiple sclerosis (MS) globally. Our objective was to adapt this global data set to the needs of Latin America, so that it can be implemented by the registries already developed and in the process of development in the region...
April 1, 2024: Revista de Neurologia
https://read.qxmd.com/read/38482703/-comorbidities-in-multiple-sclerosis-and-their-influence-on-the-choice-of-treatment
#7
REVIEW
A Barboza, V Sinay, R Alonso, E Carnero-Contentti, J Hryb, B Silva, D Tavolini, M C Ysrraelit, J Correale
Clinical trials of disease-modifying therapies (DMTs) for people with multiple sclerosis (pMS) are conducted in selected populations, excluding patients with comorbidities or concomitant medications. However, a large percentage of pMS have some additional disease, which could affect the response and choice of the DMT. The objective of this review is to assess how concurrent pathologies can impact the choice of DMTs. Relevant articles were selected through a systematic search in PubMed. Comorbidities were grouped for better classification into autoimmune, chronic infections, cardiovascular and metabolic, oncological and neuropsychiatric...
March 16, 2024: Revista de Neurologia
https://read.qxmd.com/read/38460992/cognitive-rehabilitation-program-in-patients-with-multiple-sclerosis-a-pilot-study
#8
JOURNAL ARTICLE
R M Jiménez-Morales, Y Broche-Pérez, Y Macías-Delgado, C Sebrango, S Díaz-Díaz, R Castiñeira-Rodriguez, F J Pérez-González, C Forn
INTRODUCTION: In recent years, there has been an increase of studies dedicated to cognitive rehabilitation in patients with multiple sclerosis (MS); however, few of these analyze the impact on such variables as cognitive reserve. The study aims to explore the effects of a cognitive rehabilitation program comprising a combination of cognitive and physical exercises, as well as group sessions to improve cognitive performance, emotional state, and cognitive reserve index. METHOD: Fifty patients with MS were subdivided into 2 groups: the control group, which performed aerobic exercise (n=25), and the experimental group (n=25), which participated in the integrated cognitive rehabilitation program (ICRP)...
March 2024: Neurología
https://read.qxmd.com/read/38307166/risk-of-skin-cancer-associated-with-disease-modifying-therapies-in-multiple-sclerosis-a-modern-comprehensive-evidence-review
#9
JOURNAL ARTICLE
M Brufau-Cochs, M Mansilla-Polo, D Morgado-Carrasco
The use of disease-modifying therapies (DMT) has led to a paradigm shift in the management of multiple sclerosis. A comprehensive narrative review was conducted through an extensive literature search including Medline and Google Scholar to elucidate the link between DMT and the propensity of cutaneous malignancies. Sphingosine-1-phosphate receptor modulators, such as fingolimod and siponimod are associated with a higher risk of basal cell carcinoma (BCC), but not squamous cell carcinoma, or melanoma. The associated physiopathological mechanisms are not fully understood...
January 31, 2024: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/38290874/pulmonary-manifestations-and-prognosis-of-a-cohort-of-patients-with-interstitial-lung-disease-and-positive-to-anti-th-to-autoantibodies
#10
JOURNAL ARTICLE
Mayra Mejía, Espiridión Ramos-Martínez, Leilany E Vázquez-Becerra, Deni Fernández-Badillo, Heidegger N Mateos-Toledo, Jhonatan Castillo, Andrea Estrada, Jorge Rojas-Serrano
INTRODUCTION: Th/To autoantibody may be relevant in evaluating patients with interstitial lung disease (ILD) because the clinical diagnosis of systemic sclerosis (SSc) may not be evident. The study's objective was to describe manifestations and evolution of pulmonary function in a cohort of ILD patients positive for Th/To autoantibodies. METHODS: ILD patients positive for anti-Th/To autoantibody were enrolled in this protocol. Baseline clinical features were registered, and survival analysis was performed to identify risk factors associated with worse survival...
January 29, 2024: Medicina Clínica
https://read.qxmd.com/read/38272260/euthanasia-and-assisted-suicide-in-neurological-diseases-a-systematic-review
#11
REVIEW
J M Trejo-Gabriel-Galán
OBJECTIVE: To identify the neurological diseases for which euthanasia and assisted suicide are most frequently requested in the countries where these medical procedures are legal and the specific characteristics of euthanasia in some of these diseases, and to show the evolution of euthanasia figures. METHODS: We conducted a systematic literature review. RESULTS: Dementia, motor neuron disease, multiple sclerosis, and Parkinson's disease are the neurological diseases that most frequently motivate requests for euthanasia or assisted suicide...
January 23, 2024: Neurología
https://read.qxmd.com/read/38237804/consensus-statement-of-the-spanish-society-of-neurology-on-the-treatment-of-multiple-sclerosis-and-holistic-patient-management-in-2023
#12
J E Meca-Lallana, S Martínez Yélamos, S Eichau, M Ángel Llaneza, J Martín Martínez, J Peña Martínez, V Meca Lallana, A M Alonso Torres, E Moral Torres, J Río, C Calles, A Ares Luque, L Ramió-Torrentà, M E Marzo Sola, J M Prieto, M L Martínez Ginés, R Arroyo, M Á Otano Martínez, L Brieva Ruiz, M Gómez Gutiérrez, A Rodríguez-Antigüedad Zarranz, V G Sánchez-Seco, L Costa-Frossard, M Á Hernández Pérez, L Landete Pascual, M González Platas, C Oreja-Guevara
The last consensus statement of the Spanish Society of Neurology's Demyelinating Diseases Study Group on the treatment of multiple sclerosis (MS) was issued in 2016. Although many of the positions taken remain valid, there have been significant changes in the management and treatment of MS, both due to the approval of new drugs with different action mechanisms and due to the evolution of previously fixed concepts. This has enabled new approaches to specific situations such as pregnancy and vaccination, and the inclusion of new variables in clinical decision-making, such as the early use of high-efficacy disease-modifying therapies (DMT), consideration of the patient's perspective, and the use of such novel technologies as remote monitoring...
January 16, 2024: Neurología
https://read.qxmd.com/read/38161070/sleep-disorders-in-patients-with-multiple-sclerosis-in-spain
#13
JOURNAL ARTICLE
G X Zhang, W T Zhang, S S Gao, R Z Zhao, W J Yu, G Izquierdo
OBJECTIVE: This study assesses the presence of sleep disturbances and their relationship with clinical and demographic variables in patients with MS, with a view to establishing correlations between the different variables and the frequency of sleep disturbances. METHODS: The Pittsburgh Sleep Quality Index (PSQI) was used to detect sleep disorders. We contacted patients treated at the MS unit and distributed a questionnaire (PSQI) to 221 patients, receiving 142 usable questionnaires between 8 and 30 September 2019...
2024: Neurología
https://read.qxmd.com/read/38018696/real-world-effectiveness-of-fingolimod-in-patients-with-multiple-sclerosis-in-bulgaria
#14
JOURNAL ARTICLE
I Milanov, S Ivanova, I Tournev, T Chamova, A Kaprelyan, G Slavov, V Chervenkov, K Kipriyanovska
INTRODUCTION: Fingolimod, a sphingosine-1-phosphate receptor agonist used for the treatment of multiple sclerosis (MS). Our goal was to assess the impact of fingolimod on quality of life in patients with relapsing-remitting multiple sclerosis (RRMS) after 2 years of treatment in this real-world study. PATIENTS AND METHODS: This was a 2-year, prospective, observational study conducted in Bulgaria in RRMS patients treated with fingolimod. Quality of life was assessed using the Bulgarian-language version of the MSQoL-54 scale...
November 30, 2023: Revista de Neurologia
https://read.qxmd.com/read/37934671/-characteristics-of-patients-with-systemic-sclerosis-who-develop-interstitial-lung-disease
#15
JOURNAL ARTICLE
Luis Daniel Fajardo-Hermosillo, Mario César Ocampo-Torres, Juan Rodríguez-Silverio
BACKGROUND: Systemic sclerosis associated-interstitial lung disease (SSc-ILD) show a high mortality. The factors associated SSc-ILD have shown variability in different populations. There are few studies in Mexican mestizos. OBJECTIVE: To analyze the epidemiological, clinical and paraclinical factors associated with SSc-ILD. MATERIAL AND METHODS: Cross-sectional study, where patients > 18 years of age with a diagnosis of SSc according to EULAR/ACR 2013 criteria and diagnosis of ILD by forced vital capacity (FVC) < 70% and > 5% of affected lung area on tomography were included...
October 2, 2023: Revista Médica del Instituto Mexicano del Seguro Social
https://read.qxmd.com/read/37906785/-multidisciplinary-care-and-therapeutic-advances-in-amyotrophic-lateral-sclerosis
#16
JOURNAL ARTICLE
José Manuel Matamala, Javier Moreno-Roco, Ignacio Acosta, Ricardo Hughes, Patricia Lillo, Juan Carlos Casar, Nicholas Earle
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that mainly affects the motor system, resulting in progressive weakness and muscle wasting. Despite the tremendous advances in physiopathological and clinical characterization, we do not have a curative treatment yet. The progressive and fatal course of ALS makes its management particularly complex and challenging given the diversity of symptoms presenting during the disease progression. The main goal in the treatment of ALS patients is to minimize morbidity and maximize the quality of life...
December 2022: Revista Médica de Chile
https://read.qxmd.com/read/37871567/-not-available
#17
JOURNAL ARTICLE
Laura Estefanía Arenas-Vargas, Lorena López-Reyes, Simón Cárdenas-Robledo
UNLABELLED: Introducción. El deterioro neurológico en la esclerosis múltiple es variable para cada paciente y su cuantificación se dificulta con el tiempo. El Multiple Sclerosis Outcome Assessment Consortium estableció medidas clínicas sensibles, costo-efectivas y reproducibles para medir los resultados de los estudios clínicos. Sin embargo, sus valores de referencia se desconocen y, en la atención habitual, su uso no está extendido por limitaciones de tiempo y entrenamiento...
September 30, 2023: Biomédica: Revista del Instituto Nacional de Salud
https://read.qxmd.com/read/37858891/clinically-isolated-syndrome-diagnosis-and-risk-of-developing-clinically-definite-multiple-sclerosis
#18
REVIEW
J López-Gómez, B Sacristán Enciso, M A Caro Miró, M R Querol Pascual
INTRODUCTION: In most cases, multiple sclerosis (MS) initially presents as clinically isolated syndrome (CIS). Differentiating CIS from other acute or subacute neurological diseases and estimating the risk of progression to clinically definite MS is essential since presenting a second episode in a short time is associated with poorer long-term prognosis. DEVELOPMENT: We conducted a literature review to evaluate the usefulness of different variables in improving diagnostic accuracy and predicting progression from CIS to MS, including magnetic resonance imaging (MRI) and such biofluid markers as oligoclonal IgG and IgM bands, lipid-specific oligoclonal IgM bands in the CSF, CSF kappa free light-chain (KFLC) index, neurofilament light chain (NfL) in the CSF and serum, and chitinase 3-like protein 1 (CHI3L1) in the CSF and serum...
2023: Neurología
https://read.qxmd.com/read/37807882/factors-associated-with-the-time-taken-for-diagnosis-of-amyotrophic-lateral-sclerosis-als-in-brazil-an-online-population-based-inquiry
#19
JOURNAL ARTICLE
A V Pereira-Elizeu, J de Ávila-Panisset, M L Rodrigues-da Silva, L P da Silva-Paz, K da Costa-Cunha, M L da Silva, N Monsores
OBJECTIVE: This study evaluated factors associated with the time, in months, between the onset of symptoms and the diagnosis (time taken for diagnosis) of ALS for patients in Brazil, in the year 2014. PATIENTS AND METHODS: An electronic questionnaire composed of 38 questions was developed and applied through internet-based social networks of patients. From the 210 replies, 194 were considered (86 from women, 108 from men). Most respondents were 51 to 60 years old...
October 16, 2023: Revista de Neurologia
https://read.qxmd.com/read/37805259/nodular-keloidal-scleroderma
#20
Natalia Gabriela Sanchez, Natalia Rebollo Domínguez, Eduwiges Martínez Luna, Pablo Villaseñor Ovies
Keloidal or nodular scleroderma (NS) is a variant of localized scleroderma (LS) frequently seen in patients with limited or diffuse systemic sclerosis (SSc). It presents as raised, firm plaques or nodules with extensive dermal fibrosis and hyalinized collagen bundles. We present a patient with SSc who presented with this rare entity.
October 2023: Reumatología clinica
keyword
keyword
103298
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.